Literature DB >> 31638868

The intersection of intimate partner violence and substance use among women with opioid use disorder.

Chelsea Pallatino1,2, Judy C Chang1,2, Elizabeth E Krans1,2.   

Abstract

BACKGROUND: Women with opioid use disorder (OUD) report high rates of intimate partner violence (IPV) and there is limited understanding of how IPV influences substance use behaviors among women with OUD.
Methods: Semi-structured qualitative interviews were conducted with a sample of 40 women with OUD participating in an ongoing clinical trial evaluating postpartum contraceptive utilization patterns for this population. Interviews were audio-recorded, transcribed verbatim and lasted approximately 45 min. Interview questions focused on women's perceptions and experiences with IPV and how these experiences impacted their substance use behaviors. Transcripts were coded independently in Atlas.ti and qualitatively analyzed using a general qualitative inquiry approach for emerging themes.
Results: Participants were aged 24-29, and the majority were white, single, unemployed, had Medicaid insurance and a high school degree. Although personal IPV experiences were not necessary to be selected for this qualitative sub-study, all participants reported some lifetime experience with IPV. Four overarching themes emerged: (1) women attributed physical IPV to their partner's substance use; (2) emotional abuse prevented women from fully engaging in their recovery; (3) financial abuse prevented women from gaining independence from abusive partners; and (4) women coped with IPV experiences through substance use. Conclusions: IPV had a significant influence on women's substance use behaviors including their perceived risk of relapse and treatment discontinuation. These findings demonstrate the need to integrate assessment, evaluation and management of IPV into substance use treatment settings.

Entities:  

Keywords:  Substance use; intimate partner violence; opioid use disorder

Year:  2019        PMID: 31638868     DOI: 10.1080/08897077.2019.1671296

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  7 in total

1.  Interpersonal Trauma Among Women and Men Receiving Buprenorphine in Outpatient Treatment for Opioid Use Disorder.

Authors:  Caitlin E Martin; Anna Beth Parlier-Ahmad; Lori Beck; Nicholas D Thomson
Journal:  Violence Against Women       Date:  2021-12-13

2.  What Recovery Means to Postpartum Women in Treatment for Opioid Use Disorder.

Authors:  Caroline Shadowen; Nancy Jallo; Anna Beth Parlier-Ahmad; Lisa Brown; Patricia Kinser; Dace Svikis; Caitlin E Martin
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-01-31

3.  Hidden GBV: Women and substance use.

Authors:  Eilidh Moir; Sophie Gwyther; Heather Wilkins; Gillian Boland
Journal:  Front Psychiatry       Date:  2022-08-08       Impact factor: 5.435

Review 4.  Accessibility of Treatment Among Women With Opioid Use Disorder: A Brief Review.

Authors:  Abdul Rahim Khan; Olubusola Olatunji; Danish Qureshi; Peterson Metellus; Stanley Nkemjika
Journal:  Cureus       Date:  2022-07-31

5.  Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.

Authors:  Stephani L Stancil; Melissa K Miller; Alex Duello; Sarah Finocchario-Kessler; Kathy Goggin; Rachel P Winograd; Emily A Hurley
Journal:  Harm Reduct J       Date:  2021-08-04

6.  Pregnancy and the Opioid Crisis: Heightened Effects of COVID-19.

Authors:  Ashley White; Brad Lundahl; Myranda Aryana Bryan; Akiko Okifuji; Marcela Smid; Adam J Gordon; Kristi Carlston; John Silipigni; Walitta Abdullah; Elizabeth E Krans; Amy Kenney; Gerald Cochran
Journal:  J Addict Med       Date:  2022 Jan-Feb 01       Impact factor: 4.647

7.  Relationships Between Opioid-Related Hospitalizations and Intimate Partner Violence and Child Maltreatment Hospitalizations in Pennsylvania Across Space and Time.

Authors:  Natalie Sumetsky; Jessica G Burke; Christina Mair
Journal:  J Interpers Violence       Date:  2020-08-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.